The global obesity market is projected to exceed $100 billion annually by the end of the decade, driven by unprecedented demand for GLP-1 therapies. BioRestorative’s ThermoStem ® platform is uniquely ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

StemWave shockwave therapy demonstrates success rates between 80-90% for chronic pain sufferers using acoustic wave technology The treatment effectively addresses joint pain, tendonitis, back pain, ...

For decades, regenerative medicine has held the promise of repairing the body at its deepest level — not simply masking symptoms, but addressing the root causes of decline, injury, and disease. But ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

PDA-002 is a mesenchymal stromal-like cell therapy product derived from the postpartum placenta. These cells possess potent angiogenic, immunomodulatory, and tissue-repair properties, offering a novel ...

More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, with symptoms (such as pain, stiffness and reduced movement) affecting ...

Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...

About Creative Medical Technology Holdings Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine solutions across ...

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...